During the Leipzig Interventional Course 2020 more than 70 interventional and surgical live cases are scheduled to be performed and transmitted to the auditorium.
LINC 2020 live case guide
Find all live cases and live case centers listed below.
Wednesday, January 29th:
-
,
Room 3 - Technical Forum
Case 40 – Holmium 166-SIRT of intrahepatic cholangiocellular carcinoma of the left liver lobe
Center:
Jena
Case 40 – JEN 02: male, 75 years (K-U)
Operators:
René Aschenbach,
R. Drescher
CLINICAL DATA
iCCC, Grade II of the left lobe, not resectable due to advanced liver fibrosis
IMPORTANT ITEMS
ITB waived at first line therapy resection
Intra-operative advanced fibrosis
Liver surgeons stated this as not resectable
ITB reviewed the case and recommended SIRT (probably radio-segmentectomy if possible)
PROCEDURAL STEPS 1. Right groin puncture
– 5F sheath (TERUMO) 2. Access to liver
– 5F Cobra catheter (BOSTON SCIENTIFIC) 3. Access to tumor
– Microcatheter Progreat (TERUMO) 4. Application of estimated activity
– QuiremSpheres/Holmium 166 (TERUMO) 5. Vascular closure device of the right groin
– Exoseal (CORDIS)
Wednesday, January 29th:
-
,
Room 3 - Technical Forum
Case 42 – DEB-TACE of hepatocellular carcinoma HCC of the left lobe
Center:
Jena
Case 42 – JEN 03: male, 64 years (H-D)
Operators:
René Aschenbach,
Florian Bürckenmeyer
CLINICAL DATA
22 mm HCC in the left lobe, bridging to transplant, liver cirrhosis Child-PUGH B7, in-side MILAN, no extrahepatic disease, no macrovascular invasion
IMAGING
Typical appearence in CT Scan, in-side Milan, no extrahepatic disease
PROCEDURAL STEPS 1. Right groin puncture
– 5F sheath (TERUMO) 2. Access to hepatic
– 5F Cobra catheter (BOSTON SCIENTIFIC) 3. Access to feeding vessel
– OccluSafe Micro-Catheter (TERUMO) 4. Inflation of Ballon on MicroCath to drop the arterial stump pressure 5. Embolization with doxorubicin loaded particels
– Embozene Tandem 40 μm (Varian Medical Systems)
– Doxorubicin load: 50 mg/ml 6. Embolization up to complete filling of tumor 7. Control angiography with proof of stasis 8. Vascular closure
– Exoseal 5F (CORDIS)
Wednesday, January 29th:
-
,
Room 1 - Main Arena 1
Case 28 – JEN 01
Center:
Jena
Case 28 – JEN 01
Detailed information will be shown in the video itself!
Wednesday, January 29th:
-
,
Room 3 - Technical Forum
Case 46 – Prostate artery embolization
Center:
Jena
Case 46 – JEN 04: male, 61 years
Operators:
Tobias Franiel,
René Aschenbach
CLINICAL DATA
Lower urinary tract symptoms (LUTS)
IPSS 19, mainly obstructive symptoms (0-30)
QoL 5 (0-6), IIEF-5 25
Prostate volume 75 ml, PSA 2,4 ng/ml
Qmax 8,9ml/s
Residual urinary volume 30ml
Unsuccessful medication therapy for at least 6 mo
Counselling about urol. alternative treatments
PROCEDURAL STEPS 1. Cone beam CT 2. Identification of prostate arteries and their origin 3. Cannulation of prostate arteries (left side first) 4. Guiding catheter: 4F RIM 65 cm (Merit Medical)
alternative 4F SIM1 65 cm (Merit Medical) 5. Microcatheter: Progreat 2.7F 130 cm (TERUMO)
alternative Progreat 2.0F 130 cm (TERUMO) 6. Embolic agent: Embozene 400 μm (Boston Scienfic) 7. Microcoils for embolization of possible accessory and collateral arteries: Azur18 helica 2 mm x 2 cm (TERUMO)
Wednesday, January 29th:
-
,
Room 3 - Technical Forum
Case 48 – JEN 05
Center:
Jena
Case 48 – JEN 05
Operators:
René Aschenbach,
Ioannis Diamantis
Detailed information will be shown in the video itself!
Cookie settings
We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. With the exception of strictly necessary cookies, your are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and cookie policy.
For more infos on the cookies we use and how you can manage them, please visit our cookie policy.